BioCurex, Inc.(fka BOCX)

[Gold Seeker]

<<< Saliva from cancer patients and healthy donors was tested using a slightly modified RECAF chemiluminescence assay (the chemiluminescence format was chosen for practical reasons but in light of the results found, it is anticipated that the ELISA format will perform equally well). >>>

That is an interesting statement that may tell us a few things.

First, it was run on a slightly modified chemiluminescence assay. Who would have the capability to modify the chemiluminescence assay? Not Goshen. It would be Dr. Moro. BioCurex ran those samples.

Second. Why was the chemiluminescence format chosen? Practical reasons? They developed the chemiluminescence format at Pacific BioSciences. That is why they chose the format. As Dr. Moro has stated before. This is not a simple test and know how is required. If Goshen could have modified it, then it would not be a test where know how by experts is specifically required.

Third. The Russians developed the ELISA format and Pacific BioSciences may not yet be set up to run ELISA tests.

So, What did Dr. Pennington do? He probably provided the stage 4 cancer samples. The question is why other earlier stage samples were also not processed at the same time. Dr. Moro obviously had the opportunity.